Skip to content
healthcare.dev

SOLIRIS

NDC 25682-001, ECULIZUMAB, injection, solution, concentrate, from Alexion Pharmaceuticals Inc..

Product NDC
25682-001
Status
Listed
Labeler
Alexion Pharmaceuticals Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125166
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25682-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ECULIZUMAB300 mg/30mL

Pharmacologic classes

Complement Inhibitor [EPC]; Complement Inhibitors [MoA]

Package NDCNDC-11Package
25682-001-01256820001011 VIAL in 1 CARTON (25682-001-01) / 30 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25682-001

Use it

Look up 25682-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25682-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25682-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.